Structural characteristics of isoxazol-3-ol and isothiazol-3-ol, carboxy group bioisosteres examined by X-ray crystallography and ab initio calculations

Abstract

Low-temperature single-crystal structure determinations have been carried out on isoxazol-3-ol, 5-methyl-isoxazol-3-ol, isothiazol-3-ol and 5-methylisothiazol-3-ol, the heterocyclic ring systems used as carboxy group bioisosteres in numerous neuroactive analogues of 4-aminobutyric acid (GABA) and glutamic acid. All compounds form hydrogen-bonded dimers in the solid state. The OH · · ·   N hydrogen bonds are shorter in isoxazol-3-ols than in isothiazol-3-ols. The excess molecular van der Waals volume of the sulfur-containing ring systems as compared to the corresponding isoxazol-3-ols amounts to about 15%. The sulfur substitution significantly affects the position of the 5-substituents in relation to the heterocyclic ring. Such effects may contribute to the observed differences in pharmacological effects of the structurally related isoxazol-3-ol and isothiazol-3-ol amino acids. The geometries of the compounds have been optimized by ab initio calculations at the HF/6-31G* level, and in some cases also at the MP2/6-311G** level. The gas-phase calculations are in agreement with the experimental data, especially when correction for the effects of hydrogen bonding is made, as estimated using a complex between isoxazol-3-ol and formic acid. Calculated dipole moments of isoxazol-3-ols and isothiazol-3-ols are similar. Isoxazol-3-ol is more acidic than isothiazol-3-ol by 1.7 pK_a unit as determined by ¹³C NMR titration, and the differences in acidity are believed to be one of the major factors causing the differences in the biological actions of isoxazol-3-ol amino acids and the corresponding isothiazol-3-ol analogues.

References

1. P. Krogsgaard-Larsen, Med. Res. Rev., 1988, 8, 27.
2. J. J. Hansen and P. Krogsgaard-Larsen, Med. Res. Rev., 1990, 10, 55.
3. P. Krogsgaard-Larsen, G. A. R. Johnston, D. R. Curtis, C. J. A. Game and R. M. McCulloch, J. Neurochem., 1975, 25, 803.
4. P. Krogsgaard-Larsen, G. A. R. Johnston, D. Lodge and D. R. Curtis, Nature, 1977, 268, 53.
5. P. Krogsgaard-Larsen, H. Hjeds, D. R. Curtis, D. Lodge and G. A. R. Johnston, J. Neurochem., 1979, 32, 1717.
6. L. Brehm, B. Ebert, U. Kristiansen, K. A. Wafford, J. A. Kemp and P. Krogsgaard-Larsen, Eur. J. Med. Chem., 1997, 32, 357.
7. P. Krogsgaard-Larsen, T. Honoré, J. J. Hansen, D. R. Curtis and D. Lodge, Nature, 1980, 284, 64.
8. J. Lauridsen, T. Honoré and P. Krogsgaard-Larsen, J. Med. Chem., 1985, 28, 668.
9. L. Matzen, A. Engesgaard, B. Ebert, M. Didriksen, B. Frølund, P. Krogsgaard-Larsen and J. W. Jaroszewski, J. Med. Chem., 1997, 40, 520.
10. G. T. De Titta, J. Appl. Crystallogr., 1985, 18, 75.
11. K. Frydenvang, L. M. Hansen and B. Jensen, Acta Crystallogr., Sect. C, 1995, 51, 2053.
12. F. H. Allen and O. Kennard, Chem. Des. Automation News, 1993, 8, 31.
13. A. C. Bonamartini, M. Nardelli, C. Palmieri and C. Pelizzi, Acta Crystallogr., Sect. B, 1971, 27, 1775.
14. A. C. Bonamartini, M. Nardelli and C. Palmieri, Acta Crystallogr., Sect. B, 1972, 28, 1207.
15. J. L. McVicars, M. F. Mackay and M. Davies, J. Chem. Soc., Perkin Trans. 2, 1977, 1332.
16. C. B. Vicentini, A. C. Veronese, T. Poli, M. Guarneri, P. Giori and V. Feretti, J. Heterocycl. Chem., 1990, 27, 1481.
17. K. Stratmann, J. Belli, C. M. Jensen, R. E. Moore and G. M. L. Patterson, J. Org. Chem., 1994, 59, 6279.
18. SYBYL ver. 6.2. Tripos Associates Inc., St. Louis, Missouri 63144, USA.
19. C. K. Johnson, ORTEPII. Report ORNL-5138. Oak Ridge National Laboratory, Tennessee, USA, 1976.
20. E. G. Cox, D. W. J. Cruickshank and J. A. S. Smith, Proc. R. Soc. London, 1958, 247, 1; R. W. G. Wyckoff, Crystal Structures, The Structure of Benzene Derivatives, Interscience, New York, 1969, vol. 6.
21. J. Goerdeler and W. Mittler, Chem. Ber., 1963, 861.
22. S. Scheiner, Rev. Comp. Chem., 1985, 2, 165.
23. R. Slack and K. R. H. Woolbridge, Adv. Heterocycl. Chem., 1965, 4, 107; A. Braibanti and M. T. L. Mangia, Gazz. Chim. Ital., 1981, 111, 71.
24. T. Halgren, J. Comput. Chem., 1996, 17, 490.
25. W. J. Hehre, L. Radom, P. v. R. Schleyer and J. A. Pople, Ab initio Molecular Orbital Theory, Wiley, New York, 1985.
26. I. Iwai and N. Nakamura, Chem. Pharm. Bull., 1966, 14, 1277.
27. S. N. Lewis, G. A. Miller, M. Hausmann and E. C. Szamborski, J. Heterocycl. Chem., 1971, 8, 571.
28. R. H. Blessing, Crystallogr. Rev., 1987, 1, 3; J. Appl. Crystallogr., 1989, 22, 396.
29. G. M. Sheldrick, Acta Crystallogr., Sect. A, 1990, 46, 467.
30. G. M. Sheldrick, SHELXL93. Program for the Refinement of Crystal Structures. University of Göttingen, Germany, 1995.
31. International Tables for Crystallography, Kluwer Academic Publishers, London, 1993, vol. C, Tables 4.2.6.8 and 6.1.1.4.
32. Spartan SGI version 4.0.3 GL Wavefunction Inc. 18401 von Karman, suite 370, Irvine, CA 92715.
33. Gaussian 94 revision D.1, M. J. Frisch, G. W. Trucks, H. B. Schlegel, P. M. W. Gill, B. G. Johnson, M. A. Robb, J. R. Cheeseman, T. Keith, G. A. Petersson, J. A. Montgomery, K. Raghavachari, M. A. Al-Laham, V. G. Zakrzewski, J. V. Ortiz, J. B. Foresman, J. Cioslowski, B. B. Stefanov, A. Nanayakkara, M. Challacombe, C. Y. Peng, P. Y. Ayala, W. Chen, M. W. Wong, J. L. Andres, E. S. Replogle, R. Gomperts, R. L. Martin, D. J. Fox, J. S. Binkley, D. J. Defrees, J. Baker, J. P. Stewart, M. Head-Gordon, C. Gonzales and J. A. Pople, Gaussian, Inc., Pittsburgh, 1995.